semaglutide and ibd Patients with stable inflammatory bowel disease (IBD) comorbid obesity and/or diabetes who started GLP-1 receptor agonists (semaglutide or tirzepatide) alongside ongoing treatment did not have a lower risk for the relapse GLP-1 with Crohn's Disease: Safety,

Regarding direct anti-tumor effects, studies have demonstrated that GLP-1RAs exhibit multiple functions, including inhibiting tumor cell proliferation, inducing apoptosis, and preventing tumor cell migration and invasion

These results suggest a relatively consistent risk signal in this specific population compared to the broader cohort

Canadian Family Physician

So a lot of pharmacies will require some information from doctors who prescribe it things like documentation of symptoms

In this brief review, we shall discuss recent important evidences of the potential clinical benefit of the incretin effect on cardiovascular system as well as the biological mechanisms, which underlie these effects

When comparing pricing, avoid assuming a program is cheapest unless current, documented data supports it